Valion Bio regains Nasdaq compliance with $1 minimum bid price rule
Bitget2026/09/22 12:11- Valion Bio regained compliance with Nasdaq’s $1 minimum bid price rule under Listing Rule 5550(a)(2).
- Nasdaq notified the company that it met the requirement by holding a closing bid of at least $1 for the required period.
- Nasdaq’s listing staff closed the compliance matter.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Treasury yields surge hits emerging Asia! Bond spreads approach record lows, raising capital outflow risks
The 10-year U.S. Treasury yield has surged to 5.11%, reaching its highest level since 2007. The yield spread in emerging Asia is nearing historical extremes, raising risks of capital outflows and currency depreciation. Central banks may be forced to maintain high interest rates.
Updated Version 1 - Qualcomm and Apple Extend Chip Licensing Agreement
Qualcomm Renews Patent License Deal With Apple
Litecoin token has its moment as network activity booms
Crypto prices
More
